Potent antitumor activity of cabozantinib, a c‐<scp>MET</scp> and <scp>VEGFR</scp>2 inhibitor, in a colorectal cancer patient‐derived tumor explant model

Eun‐Kee Song(University of Colorado Cancer Center), John J. Arcaroli(University of Colorado Cancer Center)

International Journal of Cancer

September 20, 2014

10.1002/ijc.29225

Cited by 61

Related Papers

Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model

|British Journal of Cancer|2013|37

The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy

|Oncotarget|2017|22